EASL Studio Podcast S5 E5: JHEP Live: The new nomenclature for SLD: A multidisciplinary evaluation and approach

EASL Studio Podcast S5 E4: PBC: The itch we need to scratch

EASL Studio Podcast S5 Special Edition: Highlights from the EASL SLD Summit 2023

EASL Studio Podcast S5 E3: Zoonotic Hepatitis E – What’s hot in 2023?

EASL Studio Podcast S5 E2: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways

EASL Studio Podcast S5 E1: What is really new in the EASL CPG on ACLF?

EASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023

EASL Studio Podcast: EASL Congress 2023: Back to the future

EASL Studio Podcast: Practice changing highlights from EASL Congress 2023

EASL Studio Podcast: United we stand: Global societies collaborating to beat liver disease

EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

EASL Studio Podcast S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio Podcast S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

EASL Studio Podcast S4 E19: HDV: The devil becomes treatable

EASL Studio Podcast S4 E18: Liver nurses in Europe: Are there enough and can they do more?

EASL Studio Podcast S4 E17: Albumin in cirrhosis: For all, for some, for none